Science

Mar 10, 2025, 09:12

Myeloma Paper of the Day, March 10th, suggested by Robert Orlowski

Robert Orlowski, Florence Maude Thomas Cancer Research Professor at the University of Texas MD Anderson Cancer Center, shared a post on X:

“Myeloma Paper of the Day: Myeloma cell intrinsic ANXA1 elevation and T cell dysfunction contribute to BCMA-negative relapse after CAR-T therapy, and ANXA1 inhibition may effectively diminish BCMA-negative myeloma.”

“Myeloma cell intrinsic ANXA1 elevation and T cell dysfunction contribute to BCMAnegative relapse after CAR-T therapy”

Authors: Shuangshuang Yang, Guixiang Wang, Jiahuan Chen, Wu Zhang, Jing Wu, Weiqing, Liu, Ling Bai, Peide Huang, Jianqing Mi, Jie Xu.

More posts featuring Robert Orlowski.

BCMA-negative myeloma cancer CAR-T therapy Guixiang Wang Jiahuan Chen Jianqing Mi Jie Xu Jing Wu Ling Bai LIU Myeloma Paper of the Day OncoDaily Oncology Peide Huang Robert Orlowski Shuangshuang Yang Weiqing Wu Zhang

FDA Priority Review Granted for TAR-200 After 82% Complete Response in BCG-Unresponsive Bladder Cancer

Paolo Tarantino: AACR Journals' Power Move for Reviewers

Best Immunotherapy Highlights from ESMO TAT ASIA 2025 You Shouldn't Miss

Oncologist Near Me – Nagashree Seetharamu: A Journey of Healing, Mentorship, and Leadership

Mohit Manrao: FDA Grants Priority Review for sBLA in Resectable Early-Stage Gastric and GEJ Cancers